Global X Genomics & Biotechnology ETF Rating $8.63 -0.09 (-1.03%) Closing price 03:56 PM EasternExtended Trading$8.78 +0.15 (+1.74%) As of 05:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock Global X Genomics & Biotechnology ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.GNOM Aggregate RatingModerate Buy 2.68Holdings in GNOM have an aggregate rating of Moderate Buy based on 631 analyst ratings issued in the past year covering 47 companies (95.1% of the portfolio).GNOM Aggregate Price Target$8.63High Prediction$8.63Average Prediction$8.63Low Prediction$8.63Holdings in GNOM have an aggregate price target of $8.63 and a range of $8.63 to $8.63 covering 47 companies (95.1% of the portfolio).GNOM Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy8 Buy rating(s)Moderate Buy26 Moderate Buy rating(s)Hold12 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Global X Genomics & Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 47 GNOM Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.16%ALNYAlnylam Pharmaceuticals$320.53-1.3%4.0439 of 5 stars2.80$346.13 8.0%25News CoverageAnalyst ForecastAnalyst Revision5.07%CRSPCRISPR Therapeutics$65.13+18.2%2.6898 of 5 stars2.53$71.75 10.2%17Insider TradeAnalyst RevisionGap UpHigh Trading Volume4.98%ILMNIllumina$96.14-1.8%4.8516 of 5 stars2.40$125.11 30.1%20Analyst Revision4.35%QGENQiagen$48.35+0.2%3.7493 of 5 stars2.30$49.40 2.2%10Positive News4.32%MRNAModerna$31.26-2.9%4.2883 of 5 stars2.04$46.61 49.1%25Trending NewsOptions VolumeAnalyst Revision4.16%GHGuardant Health$46.46-1.7%4.5773 of 5 stars3.05$54.45 17.2%21Positive News4.12%NTRANatera$138.90-3.1%2.7181 of 5 stars3.00$184.63 32.9%15Positive News4.01%TECHBio-Techne$52.04-2.3%4.8726 of 5 stars2.50$70.00 34.5%12Analyst Revision4.00%RAREUltragenyx Pharmaceutical$26.31-4.0%4.3808 of 5 stars2.93$83.64 217.9%14Trending NewsAnalyst RevisionHigh Trading Volume3.96%LEGNLegend Biotech$41.59-1.3%3.5793 of 5 stars2.91$73.33 76.3%11News CoverageAnalyst ForecastAnalyst Revision3.62%RNAAvidity Biosciences$33.76-0.8%2.1884 of 5 stars3.06$66.35 96.5%173.57%BNTXBioNTech$110.02-0.9%1.4552 of 5 stars2.83$136.58 24.1%18Analyst Forecast3.51%VRTXVertex Pharmaceuticals$459.81-0.7%4.7272 of 5 stars2.54$511.71 11.3%28Positive NewsAnalyst Revision3.49%BMRNBioMarin Pharmaceutical$57.29-1.9%4.9888 of 5 stars2.75$93.78 63.7%24News CoveragePositive NewsAnalyst ForecastAnalyst Revision2.76%WGSGeneDx$77.87-3.2%3.8105 of 5 stars2.78$92.33 18.6%92.63%VCYTVeracyte$23.51-2.9%3.5838 of 5 stars2.70$40.90 74.0%10News Coverage2.63%TWSTTwist Bioscience$35.17-1.9%4.3037 of 5 stars2.70$50.40 43.3%10News Coverage2.39%ARWRArrowhead Pharmaceuticals$16.76-11.1%3.865 of 5 stars2.75$43.71 160.8%8Positive News2.17%AAgilent Technologies$113.97-2.1%4.7295 of 5 stars2.54$139.77 22.6%132.11%BEAMBeam Therapeutics$20.75+1.5%2.0678 of 5 stars3.00$48.75 134.9%15Gap Up1.98%GILDGilead Sciences$108.22-0.5%4.8943 of 5 stars2.77$111.38 2.9%26Trending NewsInsider TradeAnalyst Revision1.85%BMYBristol Myers Squibb$47.40-1.4%4.8945 of 5 stars2.32$57.69 21.7%22Trending NewsAnalyst Revision1.77%LLYEli Lilly and Company$771.78+1.3%4.979 of 5 stars2.75$1,012.56 31.2%20Trending News1.64%TXG10x Genomics$12.14-2.5%4.465 of 5 stars2.46$14.13 16.4%131.29%NTLAIntellia Therapeutics$12.06+1.9%4.4155 of 5 stars2.65$33.37 176.7%20Gap Up1.25%CDNACareDx$11.91+0.8%4.1965 of 5 stars2.67$29.33 146.3%6News CoverageAnalyst ForecastGap UpHigh Trading Volume1.16%SRPTSarepta Therapeutics$14.07-36.0%4.8382 of 5 stars2.40$56.50 301.6%25Trending NewsAnalyst ForecastAnalyst RevisionGap DownTrading HaltedHigh Trading Volume1.08%PRAXPraxis Precision Medicines$53.85-2.0%2.4652 of 5 stars2.78$94.11 74.8%9News CoverageAnalyst ForecastAnalyst Revision1.02%WVEWAVE Life Sciences$8.34+4.1%4.584 of 5 stars2.92$20.15 141.7%13Analyst Forecast0.92%VERVVerve Therapeutics$10.91-0.4%2.9039 of 5 stars2.33$14.57 33.6%90.87%QUREuniQure$14.99-1.4%2.6014 of 5 stars2.91$37.82 152.3%11Positive News0.63%CVACCureVac$5.39-0.2%4.761 of 5 stars2.20$6.83 26.8%5Positive News0.61%MYGNMyriad Genetics$4.47-7.3%4.5924 of 5 stars2.13$14.38 221.8%16News CoveragePositive News0.59%VIRVir Biotechnology$5.41-1.5%3.5866 of 5 stars2.88$30.25 459.1%8News Coverage0.59%STOKStoke Therapeutics$13.22+7.0%4.2364 of 5 stars3.29$25.80 95.2%7Analyst ForecastGap UpHigh Trading Volume0.58%PSNLPersonalis$6.19-4.5%3.3561 of 5 stars3.00$7.67 23.9%60.49%FLGTFulgent Genetics$17.78-1.9%4.0588 of 5 stars2.50$24.00 35.0%20.48%PRMEPrime Medicine$4.13+5.9%3.8264 of 5 stars2.75$9.25 124.0%8News CoverageAnalyst ForecastAnalyst RevisionHigh Trading Volume0.48%SANASana Biotechnology$4.63+4.0%3.2931 of 5 stars3.00$9.17 98.0%7Positive NewsGap Up0.48%RGNXREGENXBIO$8.16-6.1%4.0408 of 5 stars2.83$31.63 287.6%6News Coverage0.48%PACBPacific Biosciences of California$1.37-1.4%1.8741 of 5 stars2.44$2.06 50.4%9Positive NewsGap Up0.41%ARCTArcturus Therapeutics$13.50-0.3%1.9703 of 5 stars3.11$54.00 300.0%90.38%MRVIMaravai LifeSciences$2.43-3.2%3.5345 of 5 stars2.25$6.64 173.2%12Positive News0.35%RCKTRocket Pharmaceuticals$3.04-9.0%4.8464 of 5 stars2.41$18.60 511.8%17Trending News0.27%CRGXCARGO Therapeutics$4.57-0.4%2.3335 of 5 stars1.86$15.40 237.0%7Positive NewsHigh Trading Volume0.21%ALLOAllogene Therapeutics$1.25+0.8%3.6711 of 5 stars2.90$8.44 575.6%10News CoveragePositive News0.20%SGMOSangamo Therapeutics$0.51+5.7%2.7496 of 5 stars2.67$4.50 782.0%6Positive NewsGap Up This page (NASDAQ:GNOM) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Genomics & Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
